Recombinant Camelid monoclonal antibody expressed in CHO binding to Human LCP1. The antibodiess, especially camelid antibodiess, binding to the tandem actin binding domain in L-plastin, but not to the single actin binding domains. It further relates to the use of those antibodiess to limit cell invasion and metastasis in cancer.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-801-sdAb | Recombinant Anti-human LCP1 VHH Single Domain Antibody | WB, IP, ICC, FC, FA | Llama VHH |
TAB-0071CL-VHH | Anti-Human LCP1 VHH Single Domain Antibody (TAB-0071CL-VHH) | ELISA, FC | Single domain antibody |
TAB-0072CL-VHH | Anti-Human LCP1 VHH Single Domain Antibody (TAB-0072CL-VHH) | ELISA, FC | Single domain antibody |
There are currently no Customer reviews or questions for TAB-487CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.